| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 95.56% | 95.97% | 96.58% | 96.15% | 95.80% | 96.71% |
| Debt | 3.66% | 3.46% | 2.55% | 2.96% | 3.06% | 3.25% |
| Others (incl. cash) | 0.78% | 0.57% | 0.87% | 0.89% | 1.14% | 0.04% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Healthcare | 42,533 | 39.52 | 9.75% | -0.80%↓ |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 1,99,824 | 36.3 | 8.96% | 0.75%↑ |
| Piramal Pharma Ltd. | Healthcare | 12,46,805 | 25.75 | 6.36% | -0.36%↓ |
| Rubicon Research Ltd. | Healthcare | 1,51,995 | 24.61 | 6.08% | -0.73%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 1,46,132 | 24.43 | 6.03% | -0.15%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 27,355 | 22.34 | 5.51% | -0.49%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 40,333 | 19.36 | 4.78% | -0.25%↓ |
| Emcure Pharmaceuticals Ltd. | Healthcare | 84,054 | 16.33 | 4.03% | 0.19%↑ |
| Laurus Labs Ltd. | Healthcare | 80,000 | 15.84 | 3.91% | 1.55%↑ |
| Neuland Laboratories Ltd. | Healthcare | 7,242 | 15.46 | 3.82% | -0.29%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 1,30,366 | 12.12 | 2.99% | -0.36%↓ |
| Alkem Laboratories Ltd. | Healthcare | 23,236 | 12 | 2.96% | - |
| Zydus Lifesciences Ltd. | Healthcare | 89,621 | 10.41 | 2.57% | 0.01%↑ |
| Ipca Laboratories Ltd. | Healthcare | 50,483 | 9.73 | 2.40% | -0.06%↓ |
| Fortis Healthcare Ltd. | Healthcare | 1,20,183 | 9.25 | 2.28% | -0.41%↓ |
| Zydus Wellness Ltd. | Consumer Staples | 1,73,510 | 8.9 | 2.20% | -0.07%↓ |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 61,718 | 8.87 | 2.19% | -0.12%↓ |
| Senores Pharmaceuticals Ltd. | Healthcare | 60,946 | 8.45 | 2.08% | -0.07%↓ |
| Shaily Engineering Plastics Ltd. | Materials | 24,809 | 7.6 | 1.88% | -0.12%↓ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 35,236 | 7 | 1.73% | 0.05%↑ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 89.35% | 88.25% | 87.60% | 86.77% | 86.16% | 86.32% |
| Consumer Staples | 2.20% | 2.27% | 2.66% | 2.82% | 2.65% | 5.27% |
| Materials | 1.88% | 2.00% | 2.02% | 2.03% | 2.23% | 1.94% |
| Chemicals | 1.38% | 1.45% | 2.28% | 2.17% | 2.14% | 2.11% |
| Services | 0.75% | 0.82% | 0.96% | 1.04% | 1.12% | 1.07% |
| Financial | - | 0.92% | 0.83% | 1.00% | - | - |
| Capital Goods | - | 0.26% | 0.23% | 0.32% | 0.59% | - |
| Insurance | - | - | - | - | 0.91% | - |
29.6 / 100
Weighted average Value score is 29.6. This indicates that portfolio is relatively reasonably valued using composite of value measures.
64.8 / 100
Weighted average Price Momentum score is 64.8. This indicates that portfolio has average momentum using composite of momentum measures.
83.1 / 100
Weighted average Quality score is 83.1. This indicates that portfolio has high quality using composite of quality measures.
66.6 / 100
Weighted average QVM score is 66.6. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
